AACE Cardiometabolic Conference 2021 (Videos)

Harnessing Clinical Expertise for Cardiometabolic Health

Delve into the Depths of Evidence-Based Practice

An annual gathering of renowned experts in endocrinology and cardiometabolic disease provides a transformative platform for collaboration, knowledge acquisition, and continuing medical education (CME/CE). Through cutting-edge lectures, engaging workshops, expert discussions, and peer-reviewed abstracts, attendees immerse themselves in the latest advancements and best practices in this field.

Empowering Patient Care through Evidence-Based Decision-Making

By the conclusion of this conference, participants will emerge equipped with the ability to:

• Implement the most current clinical practice guidelines in the management of cardiometabolic diseases, including type 2 diabetes, cardiovascular disease, obesity, and chronic kidney disease.
• Distill the key characteristics of evidence-based assessments and treatment options for patients with cardiometabolic conditions.
• Identify the barriers that hinder effective management of risk factors and the ability of diverse patient populations to adhere to lifestyle recommendations that promote health.
• Engage in discussions on controversial topics in cardiovascular risk management and explore alternative approaches to reach consensus.

A Multidisciplinary Exploration of Clinical Frontiers

This virtual conference experience, designed by and for healthcare professionals, offers participants the opportunity to connect with colleagues across disciplines for three days of in-depth learning. Attendees gain access to a comprehensive program that encompasses:

• State-of-the-art lectures that delve into the latest scientific advancements
• Enhanced learning workshops that provide hands-on training and skill development
• Interactive industry product theaters that showcase innovative technologies
• Abstracts that offer a glimpse into ongoing research and clinical trials
• 12.5 CME/CE credits
• On-demand access to conference materials through October 10, 2022

Translational Medicine in Action: Focus on Clinical Applications

The conference delves into key areas of translational medicine and clinical practice, exploring evidence-based guidelines for the following topics:

• Obesity medicine, nutrition, and wellness
• Type 2 diabetes and cardiovascular risk/heart failure
• Chronic kidney disease, renal failure, and diabetes technology
• SGLT-2 inhibitors, GLP-1 receptor agonists, and RAS inhibitors
• NASH/NAFLD
• Hypertension
• Dyslipidemia

Optimizing Patient Outcomes through Immersive Learning

Participants have the opportunity to immerse themselves in the most relevant clinical approaches and technological advancements, empowering them to:

• Improve patient outcomes through personalized treatment plans
• Engage in discussions on real-world challenges and effective strategies for self-management
• Access cutting-edge research and innovation to stay at the forefront of patient care

Navigating the Conference Program

The conference unfolds over three days, featuring a diverse range of presentations and workshops:

Day 1
– Informational Session: Diabetes Survey Results
– Informational Session: AACE’s Obesity Health Research Initiative
– Informational Session: AACE’s Initiative on Clinical Interpretation of CGM Reports
– Clinical Conversations on Diabetes Technology
– Cardiometabolic Health: What is New in Adrenal, Thyroid, and Bone in 2021

Day 2
– Welcome and Overview
– Cardiovascular Health in Women
– Post Bariatric Surgery Results: Surgeon and Endocrinologist Perspectives
– Fatty Liver Through the Ages
– Structural Inequities and Diabetes: Challenges and Solutions
– 2021 Controversies in Diabetes: Workshop Session 1
– Beyond LDL: Workshop Session 1
– Lifestyle Interventions for Cardiometabolic Health: Workshop Session 1
– The Emerging Role of the Liver: Workshop Session 1
– Beyond LDL: Workshop Session 2
– Lifestyle Interventions for Cardiometabolic Health: Workshop Session 2
– Factors Associated With High Glycemic Variability in Patients With Diabetes Hospitalized With COVID-19
– The Efficacy and Safety of a SGLT2 Inhibitors on Body Weight in Obese Patients Without Diabetes
– Are We Missing NAFLD Fibrosis in Our Patients? One Endocrinologist’s Clinic Experience

Day 3
– Welcome and Recap of Saturday Sessions
– AACE DEI Initiative
– Emerging Topics in Kidney Disease Management: Non-Steroidal Mineralocorticoid Receptor Treatment
– Professional Burnout: Recognition and Management
– Is Obesity Curable?
– Diabetes Technology Related Pumps and CGM Systems: Workshop Session 3
– Estrogen and Testosterone Use in Cardiometabolic Health: Workshop Session 3
– Implications of Social Determinants of Health in Chronic Disease Management: Workshop Session 3
– Is There a Perfect Diet for Cardiometabolic Health? Workshop Session 3
– Diabetes Technology Related Pumps and CGM Systems: Workshop Session 4
– Implications of Social Determinants of Health in Chronic Disease Management: Workshop Session 4
– Practicalities of SGLT2i and GLP1RA in Both CVD and Kidney Disease: Workshop Session 4
– Estrogen and Testosterone Use in Cardiometabolic Health: Workshop Session 5
– Is There a Perfect Diet for Cardiometabolic Health? Workshop Session 5
– Practicalities of SGLT2i and GLP1RA in Both CVD and Kidney Disease: Workshop Session 5
– Closing Remarks